BHI Co., Ltd. (KOSDAQ:083650)

Verve Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,319,682	477,747	250,631	168,725	107,111	66,684
Market Cap Growth	91.44%	90.62%	48.54%	57.52%	60.62%	20.99%
Enterprise Value	1,441,101	601,803	398,482	345,711	287,880	212,803
Last Close Price	42650.00	15440.00	8100.00	6490.00	4120.00	2565.00
PE Ratio	59.27	24.37	33.36	-	-	14.71
Forward PE	32.41	68.87	68.87	68.87	68.87	68.87
PS Ratio	2.83	1.18	0.68	0.51	0.46	0.27
PB Ratio	10.60	4.10	3.40	3.41	1.66	0.68
P/TBV Ratio	12.32	4.78	4.43	5.53	2.50	0.87
P/FCF Ratio	28.82	13.46	6.34	12.29	-	20.92
P/OCF Ratio	25.55	11.96	5.73	11.07	-	19.04
EV/Sales Ratio	3.09	1.49	1.09	1.05	1.23	0.87
EV/EBITDA Ratio	39.19	21.44	15.73	18.53	-	10.66
EV/EBIT Ratio	47.23	27.34	27.04	42.67	-	18.81
EV/FCF Ratio	31.47	16.95	10.09	25.19	-	66.76
Debt / Equity Ratio	1.34	1.09	2.13	4.28	2.96	1.80
Debt / EBITDA Ratio	4.49	4.51	6.18	11.37	-	8.85
Debt / FCF Ratio	3.64	3.57	3.97	15.46	-	55.43
Asset Turnover	0.84	0.85	0.84	0.79	0.60	0.64
Inventory Turnover	49.43	42.37	65.65	74.21	58.75	43.76
Quick Ratio	0.48	0.46	0.40	0.42	0.43	0.48
Current Ratio	0.73	0.65	0.59	0.65	0.54	0.61
Return on Equity (ROE)	19.53%	20.60%	12.11%	-33.56%	-42.57%	5.43%
Return on Assets (ROA)	3.46%	2.90%	2.11%	1.21%	-4.88%	1.85%
Return on Capital (ROIC)	6.88%	5.81%	3.74%	1.96%	-7.22%	2.72%
Return on Capital Employed (ROCE)	19.90%	15.20%	14.10%	5.80%	-	6.60%
Earnings Yield	1.69%	4.10%	3.00%	-11.33%	-32.28%	6.80%
FCF Yield	3.47%	7.43%	15.76%	8.13%	-17.38%	4.78%
Buyback Yield / Dilution	3.74%	-10.02%	-19.10%	0.07%	-	-

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.